BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Biotech Bay

  Bio-Rad Releases First CE-IVD Digital PCR Test for Monitoring Chronic Myeloid Leukemia Response to Therapy

  Bio-Rad today announces the launch of the QXDx BCR-ABL %IS Kit, the first CE-IVD digital PCR test that can monitor the molecular response of patients with CML to therapy, and it does so more precisely and reliably than other available technologies.

  December 5, 2017

   · 

  4 min read
• Biotech Bay

  New Aurora Advanced Flow Cytometry System from Cytek Biosciences Resonates with Researchers Around the World

  In just a few short months, the Aurora advanced flow cytometry system from Cytek Biosciences Inc. has made a distinct impression on the scientific community.

  December 5, 2017

   · 

  2 min read
• Deals

  rfxcel Acquires Frequentz Assets

  Under this agreement, rfxcel acquires Frequentz technology, patents, contracts and personnel.

  December 5, 2017

   · 

  1 min read
• Intellipharmaceutics Announces Receipt of Nasdaq Notice - Dec. 5, 2017

  The Notification Letter does not impact the Company’s listing on The Nasdaq Capital Market at this time.

  December 5, 2017

   · 

  11 min read
• Crucial Data Solutions Release: New Technology Brings EHR Data to the Forefront of Clinical Research

  Crucial Data Solutions together with strategic partner Zircon Technologies, announce the official release of a software solution to accelerate the clinical trials process.

  December 5, 2017

   · 

  3 min read
• Maetrics $16.5B Market Advantage Revealed for Medtech Firms Seizing the MDR Compliance Opportunity

  MAETRICS today publishes new research quantifying the competitive advantage that medical device manufacturers can seize by moving quickly to comply with the new European Medical Device Regulation.

  December 5, 2017

   · 

  2 min read
• Business

  Horizon Extends Industry-Leading Gene Editing IP Portfolio Through Expansion of CRISPR License Rights With ERS Genomics

  Horizon Pharma and ERS Genomics, today announce the extension of their pre-existing non-exclusive, worldwide license agreement to significantly expand Horizon’s license coverage for the use of the CRISPR gene editing technology.

  December 5, 2017

   · 

  2 min read
• 

  FDA

  Lia Diagnostics Nabs FDA OK for First and Only Flushable, Biodegradable Pregnancy Test

  Lia is the result of years of research that combines the desire for discretion with sustainable materials and novel engineering into a pregnancy test that doesn’t harm the earth.

  December 5, 2017

   · 

  3 min read
• Lone Star Bio

  Invitae’s Multigene Genetic Testing Improves Identification and Management of Hereditary Cancer Risk for Breast Cancer Patients and Their Families

  The data are being presented at the 2017 San Antonio Breast Cancer Symposium.

  December 5, 2017

   · 

  5 min read
• Biotech Bay

  Xencor Receives Milestone Payment from Amgen

  The payment is triggered by the submission of the IND Application for AMG 424 which uses Xencor’s Bispecific XmAb Technology.

  December 5, 2017

   · 

  4 min read